Skip to main content
SpringerLink
Log in

Management of and outcome for the newborn infant with congenital toxoplasmosis

  • Conference paper
Congenital toxoplasmosis

  • 379 Accesses

Abstract

As part of a National Collaborative Treatment Trial in the USA, based in Chicago, we have developed the following approach to management of the newborn infant with congenital toxoplasmosis. This approach and outcome when it is applied has been described earlier [1–11]. It also has been guided by, and included when possible, the concomitant experience developed in France in which the infected fetus is treated in utero by administration of pyrimethamine and sulfadiazine (with leucovorin) to the mother which then cross the placenta [12–16].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. McAuley J, Boyer K, Patel D et al (1994) Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. Clin Infect Dis 18:38–72

    Article  PubMed  CAS  Google Scholar 

  2. McGee T, Wolters C, Stein L et al (1992) Absence of sensorineural hearing loss in treated infants and children with congenital toxoplasmosis. Otolaryngol Head Neck Surg 106(1):75–80

    PubMed  CAS  Google Scholar 

  3. Swisher CN, Boyer K, McLeod R et al (1994) Congenital Toxoplasmosis. Sem. Ped. Neurol 1(1):4–25

    CAS  Google Scholar 

  4. Roizen N, Swisher C, Stein M et al (1995) Neurologic and Developmental Outcome in treated congenital toxoplasmosis. Pediatrics 95:11–20

    PubMed  CAS  Google Scholar 

  5. Patel DV, Holfels EM, Vogel NP et al (1996) Resolution of intracerebral calcifications in children with treated congenital toxoplasmosis. Radiology 199:433–440

    PubMed  CAS  Google Scholar 

  6. Mets M, Holfels E, Boyer KM et al (1996) Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol 122:309–324

    PubMed  CAS  Google Scholar 

  7. Remington JS, McLeod R, Desmonts G (1995) In: Remington JS, Klein J (eds). Infectious Diseases of the fetus and newborn infant. 4th Ed, WB Saunders, Philadelphia, pp 140–267

    Google Scholar 

  8. Boyer KM, McLeod RL (1996) Toxoplasma gondii (Toxoplasmosis). In: Long SS, Prober CG, Pickering LK (eds). Principles and Practice of Infectious Diseases. Churchill Livingstone, New York, pp. 645–672

    Google Scholar 

  9. Roberts F, McLeod R, Boyer K (1998) Toxoplasmosis. In: Katz S, Gershon A, Hotez P (eds) Krugman’s Infectious Diseases of Children - 10`h Ed. Mosby, St. Louis, MO, pp. 538–570

    Google Scholar 

  10. McLeod R (1994) Treatment of Congenital Toxoplasmosis. Plenary Symposium: Advances in Therapy of Protozoal Infections. ICAAC, Orlando, Florida

    Google Scholar 

  11. McLeod R, Mack D, Foss R et al (1992) Levels of pyrimethamine in sera and cerebrospinal and ventricular fluids from infants treated for congenital toxoplasmosis. Antimicrob Ag Chemother 36(5):1040–1048

    Article  CAS  Google Scholar 

  12. Desmonts G, Couvreur J (1974) Congenital Toxoplasmosis: A prospective study of 378 pregnancies. NJEM 290(20):1110–1116

    Article  CAS  Google Scholar 

  13. Daffos F, Forestier F, Capella-Pavlovsky M, Thulliez P, Aufrant C, Valenti D, Cox W (1988) Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. NEJM 318(5):271–275

    Article  PubMed  CAS  Google Scholar 

  14. Hohlfeld P, Daffos, F, Costa J-M, Thulliez P, Forestier E Vidaud M (1994) Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain reaction test on amniotic fluid NEJM 331(11):695–699

    CAS  Google Scholar 

  15. Hohlfeld P, Daffos F, Thulliez P, Aufrant C, Couvreur J, MacAleese J, Descombey D ,Forestier F (1989) Fetal Toxoplasmosis: Outcome of pregnancy and infant follow-up after in utero treatment. J Pediatrics 115(5):765–769

    Article  CAS  Google Scholar 

  16. Brezin AP, Thulliez P, Couvreur J, Nobre R, McLeod R, Mets M (1998) Ophthalmic outcome after pre-and post-natal treatment of congenital toxoplasmosis. ARVO

    Google Scholar 

  17. Eichenwald HF (1959) A study of congenital toxoplasmosis with particular emphasis on clinical manifestations, sequelae and therapy. In: Slim JC (ed) Human Toxoplasmosis. Munksgaard, Copenhagen, p. 41

    Google Scholar 

  18. Wilson CB, Remington JS, Stagno S, Reynolds DW (1980) Development of adverse sequelae in children born with subclinical congenital toxoplasma infection. Pediatrics 66(5):767–774

    PubMed  CAS  Google Scholar 

  19. Koppe JG, Loewer-Sieger DH, de Roever-Bonnet H (1986) Results of 20-year follow-up of congenital toxoplasmosis. Lancet 1:254–256

    Article  PubMed  CAS  Google Scholar 

  20. Labadie MD, Hazemann JJ (1984) Apport des bilans de santé de l’enfant pour le dépistage et l’etude épidémiologique de la toxoplasmose congénitale. Annales de Pediatrie 31(10):823–828

    PubMed  CAS  Google Scholar 

  21. Couvreur J, Desmonts G, Aron-Rosa D (1984) Le prognostic oculaire de la toxoplasmose congénitale: rôle du traitment. Annales de Pediatrie 31(10):855–858

    PubMed  CAS  Google Scholar 

  22. Dorangeon PH, Fay R, Marx-Chemla C, Leroux B, Harika G, Dupouy D, Quereux C, Choisy H, Pinon JM, Wahl P (1990) Passage transplacentaire de l’association pyriméthamine-sulfadoxine lors du traitement anténatal de la toxoplasmose congénital. La Presse Medicale 19(44):20–36

    Google Scholar 

  23. Villena I, Aubert D, Leroux B, Dupouy D, Talmud M, Chemla C, Trenque T, Schmit G, Quereux C, Guenounou M, Pluot M, Bonhomme A, Pinon JM (Reims Toxoplasmosis Group) (1998) Scan J Infect Dis 30:295–300

    Article  CAS  Google Scholar 

  24. Peyron F, Wallon M, Bernardoux C (1996) Long-term follow-up of patients with congenital ocular toxoplasmosis. NEJM 334(15):993–994

    Article  PubMed  CAS  Google Scholar 

  25. Dorangeon PH, Marx-Chemle C, Quereux C, Fay R, Leroux B, Dupouy D, Choisy H, Pinon JM, Wahl P (1992) Les risques de l’association pyriméthamine-sulfadoxine dans le traitement anténatal de la toxoplasmose. J Gynecol Obstet Biol Reprod 21:549–556

    CAS  Google Scholar 

  26. Matsui D (1994) Prevention, diagnosis and treatment of fetal toxoplasmosis. Fetal Drug Ther 21:675–689

    CAS  Google Scholar 

  27. Barbosa J and Ferreira L (1978) Sulfadoxine-pyrimethamine (Fansidar) in pregnant women with Toxoplasma antibody titers. Curr Chemother 1:134–135

    CAS  Google Scholar 

  28. Zitelli BJ, Alexander J, Taylor S, Miller KD, Howrie DL, Kuritsky JN, Perez TH, Van Thiel DH (1987) Fatal hepatic necrosis due to pyrimethamine-sulfadoxine (Fansidar®). Annals Int Med 106:393–395

    Article  CAS  Google Scholar 

  29. Mack DG, McLeod R (1984) New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimthamine and study of clindamycin, metronidazole and cyclosporin A. Antimicrob Ag Chem 26(1):26–30

    Article  CAS  Google Scholar 

Download references

Author information

Authors
  1. R. McLeod
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Boyer
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

the Toxoplasmosis Study Group and Collaborators

Editor information

Editors and Affiliations

  1. Faculté de Médecine de Grenoble, Université Joseph Fourier, Grenoble, France

    Pierre Ambroise-Thomas

  2. Statenserum Institut, Copenhagen, Denmark

    Peter Eskild Petersen

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag France

About this paper

Cite this paper

McLeod, R., Boyer, K., the Toxoplasmosis Study Group and Collaborators. (2000). Management of and outcome for the newborn infant with congenital toxoplasmosis. In: Ambroise-Thomas, P., Petersen, P.E. (eds) Congenital toxoplasmosis. Springer, Paris. https://doi.org/10.1007/978-2-8178-0847-5_15

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0847-5_15

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-59664-3

  • Online ISBN: 978-2-8178-0847-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation